Companies /Healthcare
Envista Holdings Corp
NYSE: NVST Medical Instruments & Supplies
$22.97
▲ $0.00 (+0.02%) today
Markets open · 12:35pm ET

Envista (NVST) Q1 2026 Earnings

Reported May 6, 2026, 4:12pm ET · SEC source
$0.36
Beat +14.94%
EPS · est. $0.31
$705.5M
Beat +3.74%
Revenue · est. $680.1M
+0.5%
Beating market
NVST vs S&P since report
5 quarters
Consecutive EPS beats

How Did NVST Stock React to Q1 2026 Earnings?

% change · around the report
−7%0+7%May 6May 7report 4:12pm ETearnings−0.3%−10.3%
−7%0+7%May 6May 7earnings−0.3%−10.3%
NVST −10.3%S&P 500 −0.3%
−7%0+7%May 6May 7report 4:12pm ETearnings−0.3%−10.3%
−7%0+7%May 6May 7earnings−0.3%−10.3%
NVST −10.3%NASDAQ −0.3%
−14%−7%0May 5May 14report 4:12pm ETearnings+1.9%−17.5%
−14%−7%0May 5May 14earnings+1.9%−17.5%
NVST −17.5%S&P 500 +1.9%
−14%−7%0May 5May 14report 4:12pm ETearnings+3.5%−17.5%
−14%−7%0May 5May 14earnings+3.5%−17.5%
NVST −17.5%NASDAQ +3.5%
−10.27%
Day of report
−0.21%
Next session
−1.77%
One week
+1.24%
30 days

S&P 500 over the same 30 days: +0.75%.

Did NVST Beat Earnings? Q1 2026 Results

Yes. Envista reported Q1 2026 earnings of $0.36 a share on May 6, 2026, beating the $0.31 consensus estimate by 14.9%. Revenue was $705.5M against a $680.1M estimate.

Envista Holdings posted a strong first quarter for fiscal 2026, beating Wall Street expectations on both the top and bottom lines as broad-based momentum across its dental segments drove results well ahead of forecasts. The company reported adjusted diluted EPS of $0.36, clearing the $0.31 consensus estimate by 14.94%, while revenue of $705.50 million topped the $680.07 million consensus by 3.74% and grew 14.4% year over year. The standout driver was Equipment & Consumables, which delivered 11.5% core growth and saw GAAP operating margins expand sharply to 18.9% from 14.7% a year ago, contributing to a 50% year-over-year surge in adjusted EPS and a 25% climb in adjusted EBITDA to $98.90 million. The Envista Business System contributed 120 basis points of adjusted EBITDA margin expansion, lifting the margin to 14.0%. Despite some volatility in the stock following the report, management reaffirmed full-year 2026 guidance calling for core sales growth of 2% to 4% and adjusted diluted EPS in the range of $1.35 to $1.45, signaling confidence in the company's trajectory amid a complex macro backdrop.

Key Takeaways
  • 9.5% core revenue growth driven by customer engagement and new product commercialization
  • Envista Business System (EBS) contributed 100 bps of gross margin and 120 bps of adjusted EBITDA margin expansion
  • All major businesses delivered positive growth
  • Favorable currency translation contributing 4.3 percentage points to reported growth

“We delivered a good start to 2026, with first quarter results reflecting continued strong execution and progress in support of our strategic priorities.”

Envista CEO, on the earnings call

What Was Envista's Outlook in Q1 2026?

Envista reaffirmed full-year 2026 guidance: core sales growth of 2% to 4%, adjusted EBITDA growth of 7% to 13%, adjusted diluted EPS of $1.35 to $1.45, and free cash conversion of approximately 100%. The company does not provide forward-looking estimates on a GAAP basis.

NVST YoY Financials

Q1 2026 vs Q1 2025 · SEC filings Q1 2025 Q1 2026
$0$200.0M$400.0M$600.0M$616.9M$705.5MRevenue$336.0M$390.1MGross Profit$39.0M$62.5MOperating Income$18.0M$38.7MNet Income
$0$200.0M$400.0M$600.0MRevenueGross ProfitOperating IncomeNet Income
NVST income statement, Q1 2026 versus Q1 2025
Metric Q1 2026 Q1 2025 Year over year
Revenue $705.5M $616.9M +14.4%
Gross Profit $390.1M $336.0M +16.1%
Operating Income $62.5M $39.0M +60.3%
Net Income $38.7M $18.0M +115.0%

NVST Revenue by Segment

Specialty Products & Technologies$457.8M+8.4%
Equipment & Consumables$247.7M+11.5%

Figures from SEC filings and company reports. Not investment advice.